A list of 16 best mid cap growth stocks includes United Therapeutics Corporation (NASDAQ:UTHR) analysis. Market dynamics, rate cuts impact, and financial sector challenges are discussed. UTHR shows revenue growth and product success, ranking 14th on the list.